MediciNova, Inc.
MNOV
$1.47
$0.021.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 23.03% | -8.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.03% | -8.40% | |||
| Cost of Revenue | 27.49% | -0.86% | |||
| Gross Profit | -40.00% | -56.28% | |||
| SG&A Expenses | -13.97% | 25.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.43% | -6.34% | |||
| Operating Income | 8.54% | 6.27% | |||
| Income Before Tax | 8.33% | 7.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.13% | 7.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.13% | 7.03% | |||
| EBIT | 8.54% | 6.27% | |||
| EBITDA | 8.53% | 6.28% | |||
| EPS Basic | 8.20% | 7.03% | |||
| Normalized Basic EPS | 8.48% | 6.94% | |||
| EPS Diluted | 8.20% | 7.03% | |||
| Normalized Diluted EPS | 8.48% | 6.94% | |||
| Average Basic Shares Outstanding | 0.14% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||